Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disease-causing intracellular proteins are a diverse group of molecules that contribute to various diseases when mutated, misfolded, or dysregulated. These proteins perform essential cellular functions, and their dysfunction can disrupt normal cellular processes, leading to conditions such as neurodegenerative disorders, cancer, metabolic disorders, infectious diseases, and autoimmune conditions. Targeting these proteins therapeutically is challenging due to their intracellular location, but strategies include small molecule drugs, enzyme replacement therapy, and immunotherapies.
Inhibition of mutant enzymes/proteins; restoration of wild-type protein function; degradation of mutant proteins; immune-mediated targeting of protein-derived peptides
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disease-Causing Intracellular Proteins.